---
title: "Firefly Neuroscience Revises CTO Bonus Structure to Discretionary Annual Payment"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/274869201.md"
datetime: "2026-02-04T21:18:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274869201.md)
  - [en](https://longbridge.com/en/news/274869201.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274869201.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/274869201.md) | [English](https://longbridge.com/en/news/274869201.md)


# Firefly Neuroscience Revises CTO Bonus Structure to Discretionary Annual Payment

Firefly Neuroscience Inc. has amended the employment terms for its Chief Technology Officer, Gil Issachar. Under the new agreement, Mr. Issachar’s automatic annual bonus will be replaced with eligibility for a discretionary annual bonus of up to one month of his gross salary. Additionally, the company will pay out any outstanding bonuses accrued through December 31, 2025. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Firefly Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-012246), on February 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### 相關股票

- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [Firefly Neuroscience (AIFF.US)](https://longbridge.com/zh-HK/quote/AIFF.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [iShares US Medical Devices (IHI.US)](https://longbridge.com/zh-HK/quote/IHI.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [SPDR S&P Health Equip (XHE.US)](https://longbridge.com/zh-HK/quote/XHE.US.md)

## 相關資訊與研究

- [Top NeurAxis Insiders Make Bold Moves With Fresh Stock Buys](https://longbridge.com/zh-HK/news/281670217.md)
- [Zevenbergen Capital Investments LLC Invests $32.14 Million in Insulet Corporation $PODD](https://longbridge.com/zh-HK/news/281179756.md)
- [RBC Capital Reaffirms Their Buy Rating on Insulet (PODD)](https://longbridge.com/zh-HK/news/281669086.md)
- [08:15 ETEllipsys Vascular Access System to Return to U.S. Market in 2026](https://longbridge.com/zh-HK/news/281522014.md)
- [Thermo Fisher Scientific Introduces Gibco Cts Compleo Fill and Finish System](https://longbridge.com/zh-HK/news/281553253.md)